News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,479 Results
Type
Article (40305)
Company Profile (249)
Press Release (667925)
Section
Business (208249)
Career Advice (2039)
Deals (36045)
Drug Delivery (93)
Drug Development (81867)
Employer Resources (169)
FDA (16408)
Job Trends (15446)
News (351422)
Policy (33383)
Tag
Academia (2723)
Alliances (50262)
Alzheimer's disease (1359)
Approvals (16391)
Artificial intelligence (213)
Bankruptcy (358)
Best Places to Work (12235)
Biotechnology (177)
Breast cancer (236)
Cancer (1812)
Cardiovascular disease (133)
Career advice (1699)
CAR-T (134)
Cell therapy (381)
Clinical research (65994)
Collaboration (713)
Compensation (383)
COVID-19 (2637)
C-suite (180)
Data (1717)
Diabetes (226)
Diagnostics (6524)
Earnings (86766)
Employer resources (145)
Events (114532)
Executive appointments (591)
FDA (17391)
Funding (636)
Gene therapy (265)
GLP-1 (662)
Government (4536)
Healthcare (20020)
Infectious disease (2758)
Inflammatory bowel disease (129)
Interviews (318)
IPO (16817)
Job creations (3653)
Job search strategy (1446)
Layoffs (445)
Legal (8125)
Lung cancer (262)
Manufacturing (246)
Medical device (13805)
Medtech (13810)
Mergers & acquisitions (19634)
Metabolic disorders (580)
Neuroscience (1792)
NextGen: Class of 2025 (7064)
Non-profit (4890)
Northern California (2216)
Obesity (318)
Opinion (202)
Patents (175)
People (58344)
Phase I (20596)
Phase II (29082)
Phase III (21598)
Pipeline (802)
Postmarket research (2583)
Preclinical (8695)
Radiopharmaceuticals (249)
Rare diseases (339)
Real estate (6035)
Regulatory (22525)
Research institute (2431)
Resumes & cover letters (355)
Southern California (1896)
Startups (3649)
United States (19582)
Vaccines (632)
Weight loss (218)
Date
Today (171)
Last 7 days (840)
Last 30 days (2851)
Last 365 days (35096)
2025 (5550)
2024 (35971)
2023 (41062)
2022 (52188)
2021 (56979)
2020 (55915)
2019 (49249)
2018 (37152)
2017 (32846)
2016 (32417)
2015 (38418)
2014 (31543)
2013 (26549)
2012 (28762)
2011 (29460)
2010 (27497)
Location
Africa (747)
Arizona (215)
Asia (38802)
Australia (6266)
California (5039)
Canada (1763)
China (422)
Colorado (230)
Connecticut (238)
Europe (83390)
Florida (743)
Georgia (174)
Illinois (492)
Indiana (277)
Maryland (793)
Massachusetts (3854)
Michigan (217)
Minnesota (363)
New Jersey (1428)
New York (1435)
North Carolina (886)
Northern California (2216)
Ohio (178)
Pennsylvania (1141)
South America (1139)
Southern California (1896)
Texas (734)
Utah (161)
Washington State (483)
708,479 Results for "origin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
Origin Life Sciences, Inc. announced that the Company’s abstract, titled: “NO: a Novel, Pathogen-Agnostic Therapy for Treatment-Resistant Wound Infections in the Warfighter,” has been accepted for presentation at 2024 Military Health System Research Symposium.
June 11, 2024
·
6 min read
Genetown
Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium *, a novel animal origin-free formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T cell expansion.
April 11, 2024
·
4 min read
Drug Development
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
Vera Therapeutics, Inc. announced data presentations from its Phase 2b ORIGIN trial of atacicept in immunoglobulin A nephropathy, showing that atacicept stabilized kidney function through 72 weeks and led to rapid improvements in hematuria.
May 25, 2024
·
10 min read
Genetown
Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies, and the Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, announced a collaboration to demonstrate universal automation of CGT manufacturing.
May 29, 2024
·
4 min read
Biotech Beach
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Aadi Bioscience, Inc. announced patients in the AMPECT trial whose malignant perivascular epithelioid cell tumor had gynecologic origins experienced efficacy and safety consistent with the overall study population.
March 17, 2024
·
8 min read
Press Releases
The Exosome Production Method Patent by Panacell Biotech Registered as Original Technology
October 4, 2024
·
3 min read
Policy
PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug Application for Ketamine
PharmaTher Holdings Ltd. announced receipt of an Amendment Acknowledgment Letter for its Priority Original Abbreviated New Drug Application for Ketamine from the U.S. Food and Drug Administration and assigned a Generic Drug User Fee Amendments of 2022 goal date of October 29, 2024.
May 10, 2024
·
5 min read
Press Releases
Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
October 17, 2024
·
8 min read
Press Releases
Cellular Origins and 3P innovation Collaborate to Accelerate Industrialisation of CGT Manufacturing
September 11, 2024
·
2 min read
Business
Cellular Origins, a TTP Company, Appoints Peter Crossley as Chief Operating Officer
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies, announced the appointment of Peter Crossley as Chief Operating Officer.
January 25, 2024
·
2 min read
1 of 70,848
Next